Delivery Order SPE2DB20D1004-SPE2DB23FF1L0
Award Date
1/26/23
Potential Completion Date
1/27/23
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,699.88 firm fixed-price contract is for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has an ultimate completion date of August 7, 2023 and was awarded on August 4, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,231.96 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for the treatment of diabetes. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. This award is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has an ultimate completion date of March 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,436.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Lantus Solostar 100 unit/ml 3ml, a specialty medication used for diabetes management. The contract has an ultimate completion date of May 16, 2024 and is a firm fixed-price arrangement. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,734.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of February 9, 2024, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, with a value of $1,384.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used for the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,135.27 firm fixed-price delivery order is for the supply of Lantus Solostar 100 Unit/ML 3ML, a specialty medication used for diabetes management. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This delivery order is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,268.36 firm-fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for the management of diabetes. The contract has an ultimate completion date of July 20, 2023 and was awarded on July 19, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora,...
This federal contract award, valued at $1,050.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus Solostar 100 unit/mL 3mL. The contract has a firm fixed price pricing type and an ultimate completion date of August 11, 2021. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed-price contract is for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...